Evidence supporting the use of: 3-Phenyllactic Acid
For the health condition: Staph Infections

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

3-Phenyllactic Acid (PLA) is a naturally occurring organic acid that has been found to exhibit antimicrobial activity, including activity against Staphylococcus aureus, the primary causative agent of Staph infections. Several in vitro studies have demonstrated that PLA, produced by lactic acid bacteria, can inhibit the growth of various pathogenic bacteria, including S. aureus. The mechanism is believed to involve disruption of bacterial cell membranes and interference with essential metabolic processes. Additionally, PLA has been explored as a potential additive in food preservation for its antimicrobial properties.

However, the evidence supporting the clinical use of 3-Phenyllactic Acid specifically for the treatment or prevention of Staph infections in humans is very limited. Most research is preclinical, conducted in laboratory settings or with animal models. There are no robust clinical trials or regulatory approvals supporting its use as a therapeutic agent for Staph infections in humans. Therefore, while there is scientific interest and some laboratory evidence for its antimicrobial effects, the translation of these findings into clinical practice remains unproven. The current evidence rating is 2/5, reflecting promising but preliminary scientific support without substantial clinical validation.

More about 3-Phenyllactic Acid
More about Staph Infections

Products containing 3-Phenyllactic Acid

We currently have no products on Vitabase that contain this ingredient.